Scintigraphic follow-up of the effects of therapy with hydroxyurea on splenic function in patients with sickle cell disease
✍ Scribed by Allan Santos, Vitória Pinheiro, Ana Anjos, Sílvia Brandalise, Fernanda Fahel, Mariana Lima, Elba Etchebehere, Celso Ramos, Edwaldo E. Camargo
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 90 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Hydroxyurea (HU) is the only drug approved for the induction of fetal hemoglobin. Besides this benefit, there are others such as the reduction of leukocyte and generation of nitric oxide (NO). Sickle cell anemia (SCA) is characterized by chronic hemolytic anemia and vaso‐occlusive pheno
An important purpose of blood transfusion in patients with sickle cell disease is to improve arterial oxygen saturation (SaO 2 ) and thereby reduce red cell sickling. To investigate the degree of improvement in SaO 2 by blood transfusion, we determined the hemoglobin oxygen affinity, transcutaneous
## Abstract The effect on bladder function of protectomy for colitis or Crohn's disease was studied by means of a questionnaire and by pressure/flow cystometry. Thirty-seven patients who had undergone protectomy for inflammatory bowel disease were compared with 34 control patients who had undergone